APA

Ramos E. A. S., Silva C. T. d., Manica G. C. M., Pereira I. T., Klassen L. M. B., Ribeiro E. M. S. F., Cavalli I. J., Braun-Prado K., Lima R. S., Urban C. A., Costa F. F., Noronha L. d. & Klassen G. (20170831). Worse prognosis in breast cancer patients can be predicted by immunohistochemical analysis of positive MMP-2 and negative estrogen and progesterone receptors. : Revista da Associacao Medica Brasileira (1992).

Chicago

Ramos Edneia A S, Silva Camila T da, Manica Graciele C M, Pereira Isabela T, Klassen Liliane M B, Ribeiro Enilze M S F, Cavalli Iglenir J, Braun-Prado Karin, Lima Rubens S, Urban Cicero A, Costa Fabrício F, Noronha Lucia de and Klassen Giseli. 20170831. Worse prognosis in breast cancer patients can be predicted by immunohistochemical analysis of positive MMP-2 and negative estrogen and progesterone receptors. : Revista da Associacao Medica Brasileira (1992).

Harvard

Ramos E. A. S., Silva C. T. d., Manica G. C. M., Pereira I. T., Klassen L. M. B., Ribeiro E. M. S. F., Cavalli I. J., Braun-Prado K., Lima R. S., Urban C. A., Costa F. F., Noronha L. d. and Klassen G. (20170831). Worse prognosis in breast cancer patients can be predicted by immunohistochemical analysis of positive MMP-2 and negative estrogen and progesterone receptors. : Revista da Associacao Medica Brasileira (1992).

MLA

Ramos Edneia A S, Silva Camila T da, Manica Graciele C M, Pereira Isabela T, Klassen Liliane M B, Ribeiro Enilze M S F, Cavalli Iglenir J, Braun-Prado Karin, Lima Rubens S, Urban Cicero A, Costa Fabrício F, Noronha Lucia de and Klassen Giseli. Worse prognosis in breast cancer patients can be predicted by immunohistochemical analysis of positive MMP-2 and negative estrogen and progesterone receptors. : Revista da Associacao Medica Brasileira (1992). 20170831.